Evidence of diversifying selection in human papillomavirus type 16 E6 but not E7 oncogenes

Journal of Molecular Evolution

Volumn 55, Issue 4, 2002, Pages 491-499

  DeFilippis, Victor R ^a   Ayala, Francisco J ^a   Villarreal, Luis P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adaptive evolution; Codon substitution model; Diversifying selection; DNA virus; Phylogeny

Indexed keywords

AMINO ACID COMPOSITION; ARTICLE; CODON; GENETIC SELECTION; GENETIC VARIABILITY; HAPLOTYPE; MOLECULAR EVOLUTION; NATURAL SELECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PHYLOGENY; PROTEIN INTERACTION; WART VIRUS;

AMINO ACID SEQUENCE; EVOLUTION, MOLECULAR; HUMANS; LIKELIHOOD FUNCTIONS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; SELECTION (GENETICS); ZINC FINGERS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 0036787403     PISSN: 00222844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00239-002-2344-y     Document Type: Article

References (80)

1. Altmann A, Jochmus-Kudielka I, Frank R, Gausepohl H, Moebius U, Gissmann L, Meuer SC (1992) Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7. Eur J Cancer 28:326-333
2. Alvarez-Salas LM, Wilczynski SP, Burger RA, Monk BJ, Dipaolo JA (1995) Polymorphism of the HPV-16 E6 gene of cervical carcinoma. Int J Oncol 7:261-266
3. Anisimova M, Bielawski JP, Yang Z (2001) Accuracy and power of the likelihood ratio test in detecting adaptive molecular evolution. Mol Biol Evol 18:1585-1592
4. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM (1987) Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 61:962-971
5. Bauer S, Heeg K, Wagner H, Lipford GB (1995) Identification of H-2Kb binding and immunogenic peptides from human papilloma virus tumour antigens E6 and E7. Scand J Immunol 42: 317-323
6. Beckman G, Birgander R, Sjalander A, Saha N, Holmberg PA, Kivela A, Beckman L (1994) Is p53 polymorphism maintained by natural selection? Hum Hered 44:266-270
7. Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, et al. (2001) Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 93:1325-1330
8. Bontkes HJ, van Duin M, de Gruijl TD, Duggan-Keen MF, Walboomers JM, Stukart MJ, et al. (1998) HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 78:166-171
9. Bosch F, Manos M, Muñoz N, Sherman M, Jansen A, Peto J, et al. (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87:796-802
10. Brady CS, Duggan-Keen MF, Davidson JA, Varley JM, Stern PL (1999) Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters. J Gen Virol 80:3233-3240
11. Chan SY, Ho L, Ong CK, Chow V, Drescher B, Durst M, et al. (1992) Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol 66:2057-2066
12. Comerford SA, McCance DJ, Dougan G, Tite JP (1991) Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16. J Virol 65:4681-4690
13. da Silva J, Hughes AL (1999) Molecular phylogenetic evidence of cytotoxic T lymphocyte (CTL) selection on human immunodeficiency virus type 1 (HIV-1) [Letter]. Mol Biol Evol 16: 1420-1422
14. De Campos-Lima P-O, Gavioli R, Zhang Q-J, Wallace LE, Dolcetti R, Rowe M, et al. (1993) HLA-A11 epitope loss iso-lates of Epstein-Barr virus from a highly A11 + population. Science 260:98-100
15. Dillner J (1990) Mapping of linear epitopes of human papilloma-virus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames. Int J Cancer 46:703-711
16. Dunn LA, Evander M, Tindle RW, Bulloch AL, de Kluyver RL, Fernando GJ, et al. (1997) Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal. Virology 235:94-103
17. Dyson N, Howley PM, Munger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937
18. Ellis JR, Keating PJ, Baird J, Hounsell EF, Renouf DV, Rowe M, et al. (1995) The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med 1:464-470
19. Eriksson A, Herron JR, Yamada T, Wheeler CM (1999) Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. J Gen Virol 80:595-600
20. Felsenstein J (1981) Evolutionary trees from DNA sequences: a maximum likelihood approach. J Mol Evol 17:368-376
21. Fujinaga Y, Okazawa K, Nishikawa A, Yamakawa Y, Fukushima M, Kato I, Fujinaga K (1994) Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias. Virus Genes 9:85-92
22. Goldman N, Yang Z (1994) A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol Biol Evol 11:725-736
23. Gould KG, Bangham CR (1998) Virus variation, escape from cytotoxic T lymphocytes and human retroviral persistence. Semin Cell Dev Biol 9:321-328
24. Hasegawa M, Kishino H, Saitou N (1991) On the maximum likelihood method in molecular phylogenetics [comment]. J Mol Evol 32:443-445
25. Hawley-Nelson P, Vousden K, Hubbert N, Lowy D, Schiller J (1989) HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 8:3905-3910
26. Haydon DT, Bastos AD, Knowles NJ, Samuel AR (2001) Evidence for positive selection in foot-and-mouth diesease virus capsid genes from field isolates. Genetics 157:7-15
27. Ho L, Chan SY, Chow V, Chong T, Tay SK, Villa LL, Bernard HU (1991) Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol 29:1765-1772
28. Hu X, Pang T, Guo Z, Mazurenko N, Kisseljov F, Ponten J, Nister M (2001) HPV16 E6 gene variations in invasive cervical squamous cell carcinoma and cancer in situ from Russian patients. Br J Cancer 84:791-795
29. Hughes AL, Hughes MK (1995) Natural selection on the peptide-binding regions of major histocompatibility complex molecules. Immunogenetics 42:233-243
30. Hughes AL, Nei M (1988) Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals over-dominant selection. Nature 335:167-170
31. Hughes AL, Nei M (1989) Nucleotide substitution at major histocompatibility complex class II loci: evidence for overdominant selection. Proc Natl Acad Sci USA 86:958-962
32. Hughes AL, Ota T, Nei M (1990) Positive Darwinian selection promotes charge profile diversity in the antigen-binding cleft of class I major-histocompatibility-complex molecules. Mol Biol Evol 7:515-524
33. Huibregtse JM, Scheffner M, Howley PM (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10:4129-4135
34. Jones DL, Thompson DA, Munger K (1997) Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology 239:97-107
35. Kast WM, Brandt RM, Sidney J, Drijfhout JW, Kubo RT, Grey HM, et al. (1994) Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J Immunol 152:3904-3912
36. Khanna R, Slade RW, Poulsen L, Moss DJ, Burrows SR, Nicholls J, Burrows JM (1997) Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: Evidence for immune pressure-independent genetic drift. J Virol 71:8340-8346
37. Klingelhutz AJ, Foster SA, McDougall JK (1996) Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature (London) 380:79-82
38. Kuiken CL, Foley B, Guzman E, Korber BTM (1999) Determinants of HIV-1 protein evolution. In: Crandall KA (ed) The Evolution of HIV. Johns Hopkins University Press, Baltimore, pp 432-468
39. Lambert PF, Pan H, Pitot HC, Liem A, Jackson M, Griep AE (1993) Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of-transgenic mice. Proc Natl Acad Sci USA 90:5583-5587
40. Lechner MS, Mack DH, Finicle AB, Crook T, Vousden KH, Laimins LA (1992) Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J 11:3045-3052
41. Lee SS, Weiss RS, Javier RT (1997) Binding of human virus oncoproteins to hD1g/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc Nat Acad Sci USA 94:6670-6675
42. McMichael AJ, Phillips RE (1997) Escape of human immunodeficiency virus from immune control. Annu Rev Immunol 15: 271-296
43. Monos DS, Tekolf WA, Shaw S, Cooper HL (1984) Comparison of structural and functional variation in class I HLA molecules: the role of charged amino acid substitutions. J Immunol 132:1379-1385
44. Münger K, Phelps W, Bubb V, Howley P, Schlegel R (1989) The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63:4417-4421
45. Murakami M, Gurski KJ, Steller MA (1999) Human papillomavirus vaccines for cervical cancer. J Immunother 22:212-218
46. Nicholas KB, Nicholas HB (1997) GeneDoc: A tool for editing and annotating multiple sequence alignments. Distributed by the author: www.psc.edu/biomed/genedoc
47. Nielsen R, Yang Z (1998) Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148:929-936
48. Nowak MA, May RM, Phillips RE, Rowland-Jones S, Lalloo DG, McAdam S, et al. (1995) Antigenic oscillations and shifting immunodominance in HIV-1 infections [see comments]. Nature 375:606-611
49. Phelps WC, Barnes JA, Lobe DC (1998) Molecular targets for human papillomaviruses: prospects for antiviral therapy. Antivir Chem Chemother 9:359-377
50. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, et al. (1991) Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition [see comments]. Nature 354:453-459
51. Pim D, Storey A, Thomas M, Massimi P, Banks L (1994) Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Oncogene 9:1869-1876
52. Ressing ME, Sette A, Brandt RM, Ruppert J, Wentworth PA, Hartman M, et al. (1995) Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J Immunol 154:5934-5943
53. Saitou N, Nei M (1986) The number of nucleotides required to determine the branching order of three species, with special reference to the human-chimpanzee-gorilla divergence. J Mol Evol 24:189-204
54. Sarkar AK, Tortolero-Luna G, Nehete PN, Arlinghaus RB, Mitchell MF, Sastry KJ (1995) Studies on in vivo induction of cytotoxic T lymphocyte responses by synthetic peptides from E6 and E7 oncoproteins of human papillomavirus type 16. Viral Immunol 8:165-174
55. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505
56. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136
57. Schubert EL, Hansen MF (1996) A previously unknown polymorphism located within the RB1 locus only present in Asian individuals. Hum Hered 46:118-120
58. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H (1985) Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111-114
59. Seedorf K, Krammer G, Durst M, Suhai S, Rowekamp WG (1985) Human papillomavirus type 16 DNA sequence. Virology 145:181-185
60. Smotkin D, Wettstein FO (1986) Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci USA 83:4680-4684
61. Stoppler MC, Ching K, Stoppler H, Clancy K, Schlegel R, Icenogle J (1996) Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 70:6987-6993
62. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, et al. (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer [see comments]. Nature 393:229-234
63. Strang G, Hickling JK, McIndoe GA, Howland K, Wilkinson D, Ikeda H, Rothbard JB (1990) Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity. J Gen Virol 71:423-431
64. Swofford DL (1999) PAUR*. Phylogenetic Analysis Using Parsimony (* and Other Methods). Sinauer Associates, Sunderland, MA
65. Syrjanen K, Syrjanen S (2000) Papillomavirus infections in Human Pathology, John Wiley and Sons, Ltd., West Sussex, UK
66. Tong X, Howley PM (1997) The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc Natl Acad Sci USA 94:4412-4417
67. Tornesello ML, Buonaguro FM, Meglio A, Buonaguro L, Beth-Giraldo E, Giraldo G (1997) Sequence variations and viral genomic state of human papillomavirus type 16 in penile carcinomas from Ugandan patients. J Gen Virol 78:2199-2208
68. van Duin M, Snijders PJF, Vossen MTM, Klaassen E, Voorhorst F, Verheijen RHM, et al. (2000) Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 81:317-325
69. Werness BA, Levine AJ, Howley PM (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79
70. Wheeler CM, Yamada T, Hildesheim A, Jenison SA (1997) Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol 35: 11-19
71. Wolinsky SM, Korber BT, Neumann AU, Daniels M, Kunstman KJ, Whetsell AJ, et al. (1996) Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection [see comments]. Science 272:537-542
72. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, et al. (1997) Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia [see comments]. J Natl Cancer Inst 89:796-802
73. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM (1997) Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71:2463-2472
74. Yandell DW, Campbell TA, Dayton SH, Petersen R, Walton D, Little JB, et al. (1989) Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling [see comments]. N Engl J Med 321:1689-1695
75. Yang Z (1997) PAML: A program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 13:555-556
76. Yang Z (2000) Maximum likelihood estimation on large phylogenies and analysis of adaptive evolution in human influenza virus A. J Mol Evol 51:423-432
77. Yang Z (2001) Phylogenetic analysis by maximum likelihood (PAML), London
78. Yang Z, Nielsen R, Goldman N, Pedersen A-MK (2000) Codon-Substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155:431-449
79. Zehbe I, Wilander E, Delius H, Tommasino M (1998) Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58:829-833
80. Zwerschke W, Jansen-Durr P (2000) Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. Adv Cancer Res 78: 1-29